Comments
Loading...
Curis (NASDAQ:CRIS) Stock Quotes, Forecast and News Summary
Curis Stock (NASDAQ: CRIS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Curis (CRIS) stock?
You can purchase shares of Curis (NASDAQ:CRIS) through any online brokerage.
Who are Curis (CRIS) competitors?
Other companies in Curis’s space includes: Eterna Therapeutics (NASDAQ:ERNA), HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA), CARISMA Therapeutics (NASDAQ:CARM) and Barinthus Biotherapeutics (NASDAQ:BRNS).
What is the forecast, or price target, for Curis (CRIS) stock?
Curis has a consensus price target of $14.75.
What is the current price for Curis (CRIS)?
The stock price for Curis (NASDAQ: CRIS) is $3.8 last updated November 21, 2024 at 10:36 AM EST.
Does Curis (CRIS) pay a dividend?
There are no upcoming dividends for Curis.
When is Curis (NASDAQ:CRIS) reporting earnings?
Curis’s Q4 earnings are confirmed for Thursday, February 6, 2025.
Is Curis (CRIS) going to split?
There is no upcoming split for Curis.
What sector and industry does Curis (CRIS) operate in?
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.